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Considerable interest in alkaline phosphatase
activity of mature granulocytes has been aroused
since Gomori first demonstrated alkaline phos-.
phatase activity in the cells of the blood, bone
marrow and other tissues in 1939 (1). Alkaline
phosphatase is an enzyme of unknown function
and its role in cellular metabolism is still unde-
fined. At the cellular level alkaline phosphatase is
apparently involved in nucleoprotein synthesis
and glycogen production of the cytoplasm and can
readily be demonstrated in the serum, intestinal
mucosal cells, osteoblasts, cells of the proximal
tubules of the kidneys, liver cells, reticulum cells
of bone marrow and mature polymorphonuclear
neutrophiles.
High values of leukocyte alkaline phosphatase
(LAP) activity in several clinical diseases have
been fairly well documented. Valentine and others
pioneered in establishing that LAP activity was
greatly increased in polyeythemia vera and mye-
bid metaplasia (2). LAP activity is normal in
secondary polyoythemia with chronic pulmonary
disease or congenital heart disease (3). Quigley
and Harer found that LAP activity is increased
in pregnancy in normal females as early as 30—70
days following the last menstrual period (4, 5).
In their study of 70 normal pregnant females they
found an elevated LAP score to be specific in
100% of the cases studied. Efrati studied LAP
activity in 90 pregnant females and found that
the count continued to rise to the 200—300 level
during the period of gestation and promptly fell
to normal within several days following parturi-
tion (6).
Patterson found an elevated LAP in newborns
(7). He speculated that the phosphatase activity
would disappear at the time the physiologic leuko-
eytosis fell in the newborn but he did not make
later determinations. It would be interesting to
know if "LAP elevation" would be a propor-
tionate rise and fall in relation to the total white
blood count.
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Valentine discussed the question of "stress" due
to infection, trauma, surgery, and certain disease
states which may or may not increase the eleva-
tion of LAP activity (8, 9, 10). He relates the ele-
vation to probable stimulation of the pituitary-
adrenal axis, and found that massive doses of
ACTH or oortisol will cause a rise in LAP ac-
tivity after a delay of 72 hours.
Galloway and Lowney studied fifteen patients
maintained on daily doses of 15 mg prednisone
for two weeks or more for various disease states,
but they found no significant elevation of LAP
activity with such a modest dose as 15 mg of
prednisone (11). They also studied thirty-five
patients with elevated serum alkaline phospha-
tase due to various causes. These patients had
elevated serum alkaline phosphatase and no con-
dition known to cause an elevated LAP. In this
group there was no elevation of LAP activity.
Hematobogists have noted that a low leukoeyte
alkaline phosphatase activity is often found in
chronic myebogenous leukemia, in which a small
aeroeentric chromosome at the #21 position
often is found in cases of myelogenous leukemia.
Patients with mongolism show involvement of
the same chromosome at the #21 position and
have a high LAP activity. Tough has postulated
that genetic depletion of nuclear material at this
chromosome leads to myelogenous leukemia with
low LAP activity (12). An excess of nuclear ma-
terial at this chromosome leads to mongolism and
a high LAP activity. O'Sullivan studied 200 eases
of mongolism and in each instance found in-
creased LAP activity (13).
In a recent study of LAP activity of the
lymphoma group of disease, Lacher found that
only Hodgkin's disease gave a consistent eleva-
tion (14). The patients who responded to therapy
reverted to normal in LAP activity. An exacerba-
tion of Hodgkin's disease increased LAP activity.
Patients with other lymphomas including reticu-
lum cell sarcoma, lymphosareoma, mycosis
fungoides, and lym.phocytic leukemia had no
consistent elevation of LAP score.
Low LAP scores are found in chronic myelogen-
ous leukemia, paroxysmal nocturnal hemoglobin-
uria, infectious mononucleosis, aplastie anemia
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FIG. 1. The black circles indicate the LAP
scores in patients with chronic urticaria and show
the disproportionate rise in LAP activity. The
three squares represent the LAP scores in excep-
tional cases as explained in the text. All other 29
LAP scores fall in the corridor representing a
proportionate rise in LAP activity when compared
with the total white blood count.
and some cases of pernicious anemia and thalassc-
mm. Because of the rarity of some of these
entities, it is difficult to determine if these findings
are constant (15). Collagen diseases such as lupus
erythematosus, dermatomyositis, and rheumatoid
arthritis usually give low to normal values of
LAP activity. However, it is not unusual to find
an occasional elevated LAP score in any of the
collagen diseases. Lacher in his studies of lympho-
mas reported two cases of sacroidosis with low
LAP activity (14).
Hypophosphatasia, first described by Rathbun
in 1948, is a rare, genetically controlled entity
(16). This disorder could he mistaken clinically for
rickets and only about 50 cases of this disease
have been described in the literature. The disease
is characterized clinically by a rachitic rosary,
deficient mineralization of bone, and widening of
cranial sutures. Biochemically these patients have
usually a high serum calcium, a consistently low
serum phosphatase and a low LAP score (17).
METROn5 AND MATERIALS
Kaplow described a method for staining alkaline
phosphatase in polymorphonuclear lcukocytes(18). An azo-dye can be precipitated in the cyto-
plasm of the leukocyte and scored by grading the
intensity of staining and granulation in the pre-
cipitate from 1—4.
The method of staining and scoring technic
is as follows:
1. A thin blood smear is prepared as for routine
differential WBC.
2. This slide is fixed immediately for 30—60
sec. at 0.50 C in 10% formalin in absolute metha-
nol.
3. The slide is then incubated at room tempera-
ture for 10 minutes in a mixture of sodium alpha
naphthyl acid phosphate, Fast Blue RR (an azo
dye), and .05 M proponedial buffer. This alkaline
solution permits the alkaline phosphatasc to
hydrolyze phosphate from sodium alpha naph-
thyl phosphate. Naphthalene, thus released,
combines with Fast Blue RR and precipitates in
the cytoplasm of the cell.
4. The nuclei are counterstained with methyl
green.
5. One hundred consecutive neutrophiles are
counted, rating each from zero to four, on the
basis of intensity of the precipitate in the cyto-
plasm.
Zero—Colorless
One—Diffuse pale brown, no granules
Two—Brown, with or without clumps or
brown-black ppt.
Three—Brownish black unevenly distributed
ppt.
Four—Uniform deep black granules.
The sum of the ratings of 100 cells so counted
is considered the score for a particular smear. The
normal range of LAP scores for our laboratory is
25—100.
A total of 44 patients with various skin diseases
are reported with 185 clinically normal controls.
All those patients studied were hospitalized with
a complete medical examination.
A list showing the disease entities and the num-
ber of patients in each category is:
Essential pruritus
Psoriasis
Erythrodcrm
Dermatitis herpetiformis
Darier's Disease
Poikiloderma (Jacobi)
Collagen disease
Porphyria cutanea tarda
Pyoderma
Lymphoma 2
Eczema (atopic) 5
Chronic urticaria 12
Total 44
EESULTS
If the confirmed LAP scores in those patients
with extensive non-urticarial dcrmatoscs arc
plotted against the lcukocytc count, a straight
line results, indicating a simple proportional rela-
tion. These LAP scores range from 85—160, (mean
122, average 131) with leukocytc counts of 4,500
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to 12,000 (mean 7,000, average 7,090). If a corri-
dor is defined as the line of plot 25 LAP units,
it is seen that all the LAP values of urticaria cases
lie above, and the values for all but three of the
non-urticarial dermatoscs lie within the corridor.
Of these exceptions, two arc cases of severe
crythrodermatitis and the other is atopic eczema.
It should be noted that all three of the exceptional
cases had received steroid therapy in the recent
past and prior to the determination of the WBC
and LAP activity. The other cases reported re-
ceived no steroid.
The patients with chronic urticaria were 6
males and 6 females. Their ages varied from 46 to
72 years. All patients were hospitalized and com-
plete medical examinations were performed. No
patient showed clinical evidence of a disease
previously known to produce an elevated LAP
score. None of these patients had steroid therapy
prior to his evaluation. All patients with urticaria
demonstrated a disproportionate risc in LAP
activity in relation to total white count.
DIscussIoN
Evaluation of procedure with such a wide range
of normalcy is difficult and each laboratory has
reported a different normal range for this particu-
lar technique. Although the technic is relatively
simple, an experienced technician is required and
grading is somewhat subjective. This work was
completed in a research hematology laboratory,
and the same technician did the procedure on all
subjects. Consistent results were obtained as
shown by repeated tests in the same patient.
Repeated examinations in 37 patients with proven
polycythemia vera gave consistently high values
and 76 patients with proven myelogenous leuke-.
mia gave consistently low values of LAP activity.
The disproportionate rise of LAP activity in
relation to the total WBC in this series of 12 cases
of chronic urticaria seems to be consistent.
The elevation of LAP activity is not explained
in any disease state. It may not be explained until
the exact function of alkaline phosphatase is as-
certained in the normal individual. If one specu-
lates that allergic inflammation is an inciting
factor, then it would be expected that the auto-
immune diseases as acute rheumatoid arthritis,
lupus erythematosus and dermatomyositis would
cause a like response, but these diseases usually
show a low to normal response in LAP activity.
Is it also possible that the mechanism of some
types of chronic urticaria is not allergic? Valentine
argued that "stress" of infection, trauma, preg-
nancy, surgical procedures, and the administra-
tion of massive doses of ACTH and gluco-corti-
coids elevate LAP activity. Valentine alludes to
the hypothesis that stimulation of the pituitary
adrenal axis may stimulate LAP activity. If one
recognizes the possibility that chronic urticaria
may in some instances be the result of "stress"
from some emotional problems, it would be ex-
pected that Valentine would find elevated LAP
scores in disturbed mental patients. That preg-
nancy stimulates alkaline phosphatase activity of
the leukocytes suggests other hormonal influences
may be involved. It is not inconceivable to con-
sider the possibility that some of these cases of
chronic urticaria may eventuate into polycy-
themia vera, Hodgkin's disease or other recog-
nized cause of a high LAP score. Everyone recog-
nizes the concept of hereditary atopic eczema.
Would it not be possible that a genetic factor with
tardive development of some enyzme defect or
defects may be responsible for some instances of
chronic urticaria?
5UMMARY
Twelve cases of chronic urticaria of unknown
cause gave disproportionate elevation of LAP
activity in relation to the total white blood count.
In view of the limited number of cases involved,
it suggests that chronic urticaria may be another
disease entity with a consistent elevation of
leukocyte alkaline phosphatase activity.
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